CDK7 and cervical squamous intraepithelial neoplasia: We addressed these questions by assessing the impact of inhibiting CDK7 on growth and genome stability in models of TNBC, an aggressive, genomically heterogeneous disease with high rates of aneuploidy and CIN (26, 27, 28, 29, 30).